Oragenics, Inc.
ONP-002
mild traumatic brain injury (mTBI)
Countdown
177days
Phase 2 readout · ~ Dec 31, 2026 estimated
What's at stake
Phase 2 trial results for ONP-002 in mild traumatic brain injury (mTBI) are due ~ Dec 31, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 14h ago
“The Phase IIa clinical data readout is projected before year-end 2026.”